Floré by Sun Genomics

The business model centers on a subscription service for personalized supplements. It begins with the customer purchasing a gut health test kit. This involves collecting a stool sample at home, which is then sent to a lab for whole-genome sequencing to analyze the customer's unique gut microflora. Based on this analysis, Floré creates a custom-formulated synbiotic, a blend of prebiotics and probiotics, delivered as a once-a-day capsule or powder. The initial test kit costs around $299, with subsequent monthly subscriptions for the custom probiotics priced at approximately $99. The company serves individuals experiencing a range of gut-related issues like bloating and constipation, as well as those seeking to proactively manage their digestive and immune health. It also offers specialized formulations for children, including infants.

Floré's key service is the deep personalization of its products. Utilizing whole-genome sequencing of the customer's microbiome, the company claims to identify up to 23,000 different microbes, including bacteria, fungi, and viruses. This detailed analysis allows for the formulation of probiotics from over 115 clinically validated ingredient strains tailored to address specific imbalances in an individual's gut. Customers receive their results and track progress through a dedicated mobile app, which also provides dietary recommendations. After a few months, a re-test is encouraged to adjust the formulation based on changes in the microbiome. The company has received significant financial backing, securing multiple funding rounds, including a Series A of over $9 million, to scale its operations, expand into international markets, and fund further research. Keywords: personalized probiotics, gut microbiome, whole-genome sequencing, direct-to-consumer, custom supplements, synbiotics, gut health, digestive wellness, CLIA-certified, subscription model